115 related articles for article (PubMed ID: 7357741)
1. Plasma 1,25(OH)2 vitamin D measured by radioimmunoassay and cytosol radioreceptor assay in normal subjects and patients with primary hyperparathyroidism and renal failure.
Peacock M; Taylor GA; Brown W
Clin Chim Acta; 1980 Feb; 101(1):93-101. PubMed ID: 7357741
[TBL] [Abstract][Full Text] [Related]
2. Radioreceptor assay for 1 alpha,25-dihydroxyvitamin D3.
Brumbaugh PF; Haussler DH; Bressler R; Haussler MR
Science; 1974 Mar; 183(4129):1089-91. PubMed ID: 4812038
[TBL] [Abstract][Full Text] [Related]
3. Competitive protein binding assay for 1,25-dihydroxy-vitamin D in human plasma.
Dokoh S; Morita R; Fukunaga M; Yamamoto I; Torizuka K
Endocrinol Jpn; 1978 Oct; 25(5):431-6. PubMed ID: 744168
[TBL] [Abstract][Full Text] [Related]
4. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
Hughes MR; Baylink DJ; Jones PG; Haussler MR
J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
[TBL] [Abstract][Full Text] [Related]
5. The importance of phosphate in regulating plasma 1,25-(OH)2-vitamin D levels in humans: studies in healthy subjects in calcium-stone formers and in patients with primary hyperparathyroidism.
Gray RW; Wilz DR; Caldas AE; Lemann J
J Clin Endocrinol Metab; 1977 Aug; 45(2):299-306. PubMed ID: 885994
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. Comparison of a cytosol radioreceptor assay with a radioimmunoassay for 1,25-dihydroxyvitamin D in serum or plasma.
De Leenheer AP; Bauwens RM
Clin Chim Acta; 1985 Oct; 152(1-2):143-54. PubMed ID: 3840418
[TBL] [Abstract][Full Text] [Related]
8. The assay of 1alpha,25-dihydroxyvitamin D3: physiologic and pathologic modulation of circulating hormone levels.
Haussler MR; Baylink DJ; Hughes MR; Brumbaugh PF; Wergedal JE; Shen FH; Nielsen RL; Counts SJ; Bursac KM; McCain TA
Clin Endocrinol (Oxf); 1976; 5 Suppl():151S-165S. PubMed ID: 212227
[TBL] [Abstract][Full Text] [Related]
9. Protein binding assays for 25-hydroxy, 24,25-dihydroxy and 1,25-dihydroxy metabolites of vitamin D1) in human plasma.
Keck E; Krüskemper HL; von Lilienfeld-Toal H
J Clin Chem Clin Biochem; 1981 Oct; 19(10):1043-50. PubMed ID: 6975800
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous measurement of 1.25-dihydroxy-vitamin D, 24.25-dihydroxy-vitamin D and 25-hydroxy-vitamin D from a single two milliliters serum specimen. Preliminary clinical application.
Tartarotti D; Adami S; Galvanini G; Dorizzi R; Piemonte G; Lo Cascio V
J Endocrinol Invest; 1984 Dec; 7(6):545-50. PubMed ID: 6335715
[TBL] [Abstract][Full Text] [Related]
11. The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism.
Broadus AE; Horst RL; Lang R; Littledike ET; Rasmussen H
N Engl J Med; 1980 Feb; 302(8):421-6. PubMed ID: 7351950
[TBL] [Abstract][Full Text] [Related]
12. Measurement of 1,25-dihydroxycholecalciferol in man by radioimmunoassay.
Clemens TL; Hendy GN; Papapoulos SE; Fraher LJ; Care AD; O'Riordan JL
Clin Endocrinol (Oxf); 1979; 11(2):225-34. PubMed ID: 487620
[TBL] [Abstract][Full Text] [Related]
13. An improved method for the measurement of 1,25-(OH)2D3 in human plasma.
Lambert PW; Toft DO; Hodgson SF; Lindmark EA; Witrak BJ; Roos BA
Endocr Res Commun; 1978; 5(4):293-310. PubMed ID: 752633
[TBL] [Abstract][Full Text] [Related]
14. The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.
Kaplan RA; Haussler MR; Deftos LJ; Bone H; Pak CY
J Clin Invest; 1977 May; 59(5):756-60. PubMed ID: 192763
[TBL] [Abstract][Full Text] [Related]
15. 1,25-Dihydroxycholecalciferol in human serum and its relationship with other metabolites of vitamin D-3.
Taylor CM; Hann J; St John J; Wallace JE; Mawer EB
Clin Chim Acta; 1979 Aug; 96(1-2):1-8. PubMed ID: 225061
[TBL] [Abstract][Full Text] [Related]
16. Plasma levels of vitamin D metabolites in renal diseases.
Ogura Y; Kawaguchi Y; Sakai S; Yamamoto M; Kimura Y; Oda Y; Imamura N; Tsukui I
Contrib Nephrol; 1980; 22():18-27. PubMed ID: 6995016
[TBL] [Abstract][Full Text] [Related]
17. 1,25-Dihydroxyvitamin D in biological fluids: a simplified and sensitive assay.
Eisman JA; Hamstra AJ; Kream BE; DeLuca HF
Science; 1976 Sep; 193(4257):1021-3. PubMed ID: 1085035
[TBL] [Abstract][Full Text] [Related]
18. Assay of 24R,25-dihydroxycholecalciferol in human serum.
Taylor CM
Methods Enzymol; 1980; 67():414-24. PubMed ID: 6966028
[No Abstract] [Full Text] [Related]
19. Serum concentrations of 24,25-dihydroxy vitamin D in different degrees of chronic renal failure.
Weisman Y; Eisenberg Z; Leib L; Harell A; Shasha SM; Edelstein S
Br Med J; 1980 Sep; 281(6242):712-3. PubMed ID: 7427411
[No Abstract] [Full Text] [Related]
20. Synthesis and metabolic clearance of 1,25-dihydroxyvitamin D as determinants of serum concentrations: a comparison of two methods.
Maierhofer WJ; Gray RW; Adams ND; Smith GA; Lemann J
J Clin Endocrinol Metab; 1981 Sep; 53(3):472-5. PubMed ID: 6897931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
